Validation for Clinical Use of, and Initial Clinical Experience with, a Novel Approach to Population-Based Carrier Screening using High-Throughput, Next-Generation DNA Sequencing
Open Access
- 1 March 2014
- journal article
- Published by Elsevier in The Journal of Molecular Diagnostics
- Vol. 16 (2) , 180-189
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Disease-targeted sequencing: a cornerstone in the clinicNature Reviews Genetics, 2013
- Assuring the quality of next-generation sequencing in clinical laboratory practiceNature Biotechnology, 2012
- Opportunities and Challenges Associated with Clinical Diagnostic Genome SequencingThe Journal of Molecular Diagnostics, 2012
- Next‐generation sequencing: ready for the clinics?Clinical Genetics, 2012
- Ultrasensitive detection of rare mutations using next-generation targeted resequencingNucleic Acids Research, 2011
- Committee Opinion No. 486: Update on Carrier Screening for Cystic FibrosisObstetrics & Gynecology, 2011
- Evidence-based classification of recommendations on use of genomic tests in clinical practice: Dealing with insufficient evidenceGenetics in Medicine, 2010
- Experience with carrier screening and prenatal diagnosis for 16 Ashkenazi Jewish genetic diseasesHuman Mutation, 2010
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic AnalysesScience, 2008
- Linkage Disequilibrium and Heritability of Copy-Number Polymorphisms within Duplicated Regions of the Human GenomeThe American Journal of Human Genetics, 2006